Copyright: ©Author(s) 2026.
World J Psychiatry. Nov 19, 2026; 16(11): 122026
Published online Nov 19, 2026. doi: 10.5498/wjp.122026
Published online Nov 19, 2026. doi: 10.5498/wjp.122026
Table 4 Inflammatory markers and lipid profiles at 12 weeks
| Indicator | Treatment group (12 weeks) | Control group (12 weeks) | P value |
| IL-6 (pg/mL) | 3.2 ± 0.8 | 5.1 ± 1.2 | < 0.001 |
| TNF-α (pg/mL) | 8.4 ± 1.6 | 12.3 ± 2.1 | < 0.001 |
| hs-CRP (mg/L) | 2.8 ± 0.9 | 4.3 ± 1.3 | < 0.001 |
| LDL-cholesterol (mmol/L) | 1.4 ± 0.4 | 2.1 ± 0.6 | < 0.001 |
| Total cholesterol (mmol/L) | 3.6 ± 0.7 | 4.3 ± 0.8 | < 0.001 |
| HDL-cholesterol (mmol/L) | 1.2 ± 0.3 | 1.2 ± 0.3 | 0.856 |
| Triglycerides (mmol/L) | 1.5 ± 0.6 | 1.6 ± 0.7 | 0.412 |
- Citation: Song HY, Yang Y, Sun XY, Zhang MJ, Wang SG. Serum proprotein convertase subtilisin/kexin type 9 levels correlate with depression severity in post-stroke patients. World J Psychiatry 2026; 16(11): 122026
- URL: https://www.wjgnet.com/2220-3206/full/v16/i11/122026.htm
- DOI: https://dx.doi.org/10.5498/wjp.122026